Close close-icon
notification-icon

Important Alerts:

Memorial Day Hours, view here

COVID-19 Guidance and Testing, click here

 

Close

Update on Covid-19 Vaccine

There are three vaccines that can be used to prevent severe disease and reduce transmission of COVID-19:
Pfizer-BioNTech
– Full approval in the US for ages 16 and older
–  Emergency Use Authorization for ages 5-15
–  – 2 dose vaccine series at least 21 days apart*
Moderna
– Emergency Use Authorization for ages 18 and older
– Full FDA approval pending
– 2 dose vaccine series at least 28 days apart*
Johnson & Johnson (Janssen)
– Emergency Use Authorization for ages 18 and older
– Was authorized as a single dose, but evidence points to much better effectiveness as a 2 dose series given 2 months apart

*People ages 12 through 64 years who are not moderately or severely immunocompromised—and particularly males ages 12 through 39 years—may benefit from getting their second COVID-19 vaccine dose 8 weeks after their first dose, instead of after the FDA approved or FDA-authorized 3-week (Pfizer-BioNTech) or 4-week (Moderna) interval.

Additional (Third) Dose and Booster Doses
Additional (third) doses of Pfizer and Moderna are recommended for people with moderate to severe immune compromise, ages 5 years and older, 28 days after their second dose to help stimulate their immune system. This is not the same as a Booster dose.  Only Pfizer vaccine is available for patients age 5 to 17. Patients who are moderately to severely immunocompromised can have three primary doses and two booster doses. 
See definition of Severe Immune Compromise here.

Booster doses are available for patients 12 years and older. For patients ages 12-17 who received Pfizer-BioNTech, their booster should be given 5 months after the last dose. For patients ages 18+ who received Moderna, their booster should be given 5 months after the last dose. For the Janssen/Johnson & Johnson vaccine, a second dose of any approved vaccine can be given at least two months ago after their first dose.

Second booster doses are available for patients 50 years and older who have received a first booster dose of any authorized or approved COVID-19 vaccine and patients age 12 years and older who are moderately to severely immune impaired. Patients who received the J+J vaccine as their first dose can now get 2 additional mRNA doses, or can have an mRNA booster if they had two doses of J+J vaccine. A second booster dose can be given at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.

CareMount strongly encourages our patients to receive a booster dose.

Vaccines are available by appointment in our six vaccine clinics. Schedule now.

We are offering first, second, third and booster doses of these vaccines.
Please note:
– Booster doses should be given using the same vaccine manufacturer that the person received for the primary series.
– If the same product used for the primary series is no longer available, or a different COVID-19 vaccine is desired, any COVID-19 vaccine can be used for the booster dose
– Booster doses of Moderna are being given as ½ strength as per FDA and CDC. This has been shown to be effective and doubles the world supply of Moderna boosters.

Updated April 1, 2022